Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer

被引：0
|
作者：
Andreas Ihrig
Pascal Marino Pernt
Stefanie Zschäbitz
Johannes Huber
Hans-Christoph Friederich
Till J. Bugaj
Imad Maatouk
机构：
[1] University Hospital Heidelberg,Division of Psycho
[2] National Centre for Tumor Diseases (NCT),Oncology, Department of General Internal Medicine and Psychosomatics
[3] University Hospital Heidelberg,Department of Medical Oncology
[4] Philipps-University Marburg,Department of Urology
[5] Julius-Maximilian University Würzburg,Section of Psychosomatic Medicine, Psychotherapy and Psycho
来源：
International Urology and Nephrology | 2023年 / 55卷
关键词：
Metastatic prostate cancer; Hormonal agents; Androgen deprivation therapy; Neurocognitive effects;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2733 / 2739
页数：6
相关论文
共 50 条
  • [1] Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer
    Ihrig, Andreas
    Pernt, Pascal Marino
    Zschaebitz, Stefanie
    Huber, Johannes
    Friederich, Hans-Christoph
    Bugaj, Till J. J.
    Maatouk, Imad
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (11) : 2733 - 2739
  • [2] Serum testosterone level predicts the effective time of androgen deprivation therapy in metastatic prostate cancer patients
    Wang, Yue
    Dai, Bo
    Ye, Ding-Wei
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (02) : 178 - 183
  • [3] Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer
    Agarwal, Megha
    Canan, Timothy
    Glover, Greg
    Thareja, Nidhi
    Akhondi, Andre
    Rosenberg, Joshua
    CURRENT ONCOLOGY REPORTS, 2019, 21 (10)
  • [4] Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer
    Megha Agarwal
    Timothy Canan
    Greg Glover
    Nidhi Thareja
    Andre Akhondi
    Joshua Rosenberg
    Current Oncology Reports, 2019, 21
  • [5] Use of androgen deprivation therapy for metastatic prostate cancer in older men
    Keating, Nancy L.
    O'Malley, A. James
    McNaughton-Collins, Mary
    Oh, William K.
    Smith, Matthew R.
    BJU INTERNATIONAL, 2008, 101 (09) : 1077 - 1083
  • [6] Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer Patients: A Systematic Review
    Kakarla, Meghana
    Gambo, Musa Ausaja
    Salama, Mustafa Yousri
    Ismail, Nathalie Haidar
    Tavalla, Pardis
    Uppal, Pulkita
    Mohammed, Shaza A.
    Rajashekar, Shriya
    Ravindran, Suganya Giri
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [7] The role of androgen deprivation therapy plus radiation therapy in patients with non-metastatic prostate cancer
    Zhao, Sherry
    Urdaneta, Alfredo I.
    Anscher, Mitchell S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 929 - 942
  • [8] Docetaxel or abiraterone in combination with androgen deprivation therapy for metastatic prostate cancer
    Hammerer, P.
    Manka, L.
    UROLOGE, 2019, 58 (10): : 1185 - 1197
  • [9] The depressive effects of androgen deprivation therapy in locally advanced or metastatic prostate cancer: a comparative study
    Ceylan, Yasin
    Gunlusoy, Bulent
    Koskderelioglu, Asli
    Gedizlioglu, Muhtesem
    Degirmenci, Tansu
    AGING MALE, 2020, 23 (05) : 733 - 739
  • [10] Androgen deprivation therapy in nonmetastatic prostate cancer patients: Indications, treatment effects, and new predictive biomarkers
    Fang, Dong
    Zhou, Liqun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (03) : 108 - 120
12345